ONCOLOGY PHARMA (ONPH) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 137 243 sessions, October 29, 2025 to October 29, 2026
- Largest daily move
- +300% close of November 21, 2025
- 1-year change
- +1700% closing prices, October 29, 2025 to October 29, 2026
- 1-month change
- -41.9% closing prices, September 29, 2026 to October 29, 2026
Company Description
ONCOLOGY PHARMA (OTC: ONPH) is classified in the shell companies industry within the Financial Services sector and carries a market capitalization of $3.0M.
ONPH has gained 1700.0% over the past year. The last closing price was $0.0360.
This page collects what Stock Titan holds for ONPH, including price data, latest news, and short interest trends.
Stock Performance
ONCOLOGY PHARMA (ONPH) closed at $0.0360 on October 29, 2026. Over the past 12 months, the price has gained 1700.0%.
ONPH Metrics & Rankings
Price returns through October 29, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
ONCOLOGY PHARMA has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include clinical trial. View all ONPH news →
SEC Filings
Short Interest History
Short interest in ONCOLOGY PHARMA (ONPH) currently stands at 13.4 thousand shares, representing 0.0% of the float.
Days to Cover History
Days to cover for ONCOLOGY PHARMA (ONPH) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 4.0 days.
ONPH Company Profile & Sector Positioning
ONCOLOGY PHARMA (ONPH) operates in the Shell Companies industry within the broader Financial Services sector and is listed on the OTC.
Investors comparing ONPH often look at related companies in the same sector, including KALEIDO BIOSCIENCES INC (KLDO), REBUS HLDGS INC (RBSH), CARDAX INC (CDXI), AMPIO PHARMS INC (AMPE), and BETTER THERAPEUTICS INC (BTTX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ONPH's relative position within its industry.